PND1 ASSESSING THE NET CLINICAL BENEFIT AND ABSOLUTE RISK REDUCTION OF DISEASE MODIFYING DRUGS IN RELAPSING REMITTING MULTIPLE SCLEROSIS
May 1, 2007, 00:00
10.1016/S1098-3015(10)68800-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)68800-6/fulltext
Title :
PND1 ASSESSING THE NET CLINICAL BENEFIT AND ABSOLUTE RISK REDUCTION OF DISEASE MODIFYING DRUGS IN RELAPSING REMITTING MULTIPLE SCLEROSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68800-6&doi=10.1016/S1098-3015(10)68800-6
First page :
Section Title :
Open access? :
No
Section Order :
586